• Nenhum resultado encontrado

Rapid Antiretroviral Therapy Initiation for Women in an HIV-1 Prevention Clinical Trial Experiencing Primary HIV-1 Infection during Pregnancy or Breastfeeding.

N/A
N/A
Protected

Academic year: 2016

Share "Rapid Antiretroviral Therapy Initiation for Women in an HIV-1 Prevention Clinical Trial Experiencing Primary HIV-1 Infection during Pregnancy or Breastfeeding."

Copied!
5
0
0

Texto

Loading

Referências

Documentos relacionados

Figure 1: Selection scheme of the HIV patients on antiretroviral therapy (ART) that were submitted to nutritional counseling aiming an adequate lipid profile..

HIV testing coverage during pregnancy was de fi ned as the proportion of pregnant women among parturient women admitted for delivery who received ANC and who had an HIV test

To further our understanding of the mechanisms by which HIV-1 co- infection impairs immunity to malaria in pregnancy, we investigated the effects of in vitro HIV-1 infection

Kim et al., in a retrospective cohort study involving HIV- 1 infected children with highly active antiretroviral therapy (HAART) versus HIV-1 infected children without HAART found

Molecular epidemiology of HIV-1 in Brazil: high prevalence of HIV-1 subtype B and identification of an HIV-1 subtype D infection in the city of Rio de Janeiro, Brazil.

While PAHO recognizes the value of antiretroviral therapy (ARV) in the management of HIV infection and in the prevention of perinatal transmission of HIV, Member States need to view

Although the pathogenesis of HIV infection and the general principles of therapy are the same for HIV-infected adults, adolescents, children and infants, antiretroviral treatment of

According to the studied variables, is suggested that the risk factors for vertical transmission of HIV-1 were absence of antiretroviral therapy, high viral load in the pregnant